Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain
US11717543B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 22, 2020 |
| Grant date | Aug 8, 2023 |
| Priority date | — |
| Expiry date | Apr 16, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual.The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.